https://sputnikglobe.com/20230314/rwanda-receives-mobile-units-to-produce-vaccines-1108390165.html
Rwanda Receives Mobile Units to Produce Vaccines
Rwanda Receives Mobile Units to Produce Vaccines
Sputnik International
Rwanda received six mobile vaccine production units developed by German pharmaceutical company BioNTech, Rwanda's President has said on his social media webpage.
2023-03-14T16:26+0000
2023-03-14T16:26+0000
2023-03-14T16:26+0000
africa
east africa
rwanda
disease
illness
treatment
vaccine
malaria
tuberculosis
hiv
https://cdn1.img.sputnikglobe.com/img/07e7/03/0e/1108389140_0:0:3219:1810_1920x0_80_0_0_ea9582afdd9a1e226e039e415b28785f.jpg
Rwanda received six mobile vaccine production units developed by German pharmaceutical company BioNTech, Rwanda's president has said on his social media webpage.The BioNTainers are expected to begin producing vaccines in about 12 to 18 months after they have been set up.Authorities plan to make a vaccine production hub to counter a number of diseases. The facility will be able to produce up to 100 million mRNA vaccines a year.The BioNTainers will also pioneer treatments of such diseases as malaria, tuberculosis, or HIV in the development phase.The shipment is the first of its kind for Africa. However, BioNTech plans to send similar facilities to South Africa and Senegal.
africa
east africa
rwanda
south africa
senegal
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2023
News
en_EN
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
Sputnik International
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
vaccine production, biontech, rwanda
vaccine production, biontech, rwanda
Rwanda Receives Mobile Units to Produce Vaccines
The units called BioNTainers, which are made from recycled shipping containers, have arrived in Rwanda's capital Kigali. When the units are assembled, they will set up a hub producing vaccines in order to fight illnesses that are widely spread in Africa.
Rwanda received six mobile vaccine production units developed by German pharmaceutical company BioNTech, Rwanda's president has said on his social media webpage.
The BioNTainers are expected to begin producing vaccines in about 12 to 18 months after they have been set up.
"Historic milestone today as the first BioNTainers arrived in Rwanda, exactly 3 years since the first case of COVID-19 was detected in our country. This system will allow end-to-end mRNA vaccine production in Africa for the first time," Rwandan President Paul Kagame said on his social media webpage.
Authorities plan to make a vaccine production hub to
counter a number of diseases. The facility will be able to produce up to 100 million mRNA vaccines a year.
The BioNTainers will also
pioneer treatments of such diseases as malaria, tuberculosis, or HIV in the development phase.
The shipment is the first of its kind for Africa. However, BioNTech plans to send similar facilities to South Africa and Senegal.
